TRPV1: A useful therapeutic target for patients with vulnerable coronary plaques

Medical Hypotheses

Volumn 77, Issue 3, 2011, Pages 453-455

  Li, Yan Bo ^a   Huang, Cong Xin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROPEPTIDE; VANILLOID RECEPTOR 1;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; DOWN REGULATION; HUMAN; MAST CELL; NEUROGENIC INFLAMMATION; PROTEIN EXPRESSION; SENSORY NERVE CELL; THROMBOCYTE;

DRUG DELIVERY SYSTEMS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLAQUE, ATHEROSCLEROTIC; PLATELET ACTIVATION; TRPV CATION CHANNELS;

EID: 80051812908     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.06.008     Document Type: Article

References (22)

1. Fishbein M.C. The vulnerable and unstable atherosclerotic plaque. Cardiovasc Pathol 2010, 19:6-11.
2. Li J.J., Chen J.L. Inflammation may be a bridge connecting hypertension and atherosclerosis. Med Hypotheses 2005, 64:925-929.
3. Hu C.L., Xiang J.Z., Hu F.F., Huang C.X. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque. Med Hypotheses 2007, 68:1262-1264.
4. Higuchi M.L., Gutierrez P.S., Bezerra H.G., et al. Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq Bras Cardiol 2002, 79:20-24.
5. Bot I., De Jager S.C., Zernecke A., et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007, 115:2516-2525.
6. Shepherd D.J., Miyan J.A. Without nerves, immunology remains incomplete - in vivo veritas. Immunology 2005, 116:145-163.
7. Hu C.L., Xiang J.Z., Hu F.F. Vanilloid receptor TRPV1, sensory C-fibers, and activation of adventitial mast cells. A novel mechanism involved in adventitial inflammation. Med Hypotheses 2008, 71:102-103.
8. Richardson J.D., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 2002, 302:839-845.
9. Schaible H.G., Del Rosso A., Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 2005, 31:77-101. ix.
10. Bucelli R.C., Gonsiorek E.A., Kim W.Y., et al. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther 2008, 324:1172-1180.
11. Durham P.L. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006, 46(Suppl. 1):S3-S8.
12. Groneberg D.A., Quarcoo D., Frossard N., Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy 2004, 59:1139-1152.
13. Laine P., Naukkarinen A., Heikkila L., Penttila A., Kovanen P.T. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 2000, 101:1665-1669.
14. Hegde A., Bhatia M. Neurogenic inflammation in acute pancreatitis. Jop 2005, 6:417-421.
15. Souza D.G., Mendonca V.A., De A.C.M.S., Poole S., Teixeira M.M. Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat. Br J Pharmacol 2002, 135:303-312.
16. Kohchi K., Takebayashi S., Hiroki T., Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985, 71:709-716.
17. Scotland R.S., Chauhan S., Davis C., et al. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res 2004, 95:1027-1034.
18. Szallasi A., Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51:159-212.
19. Bot I., De Jager S.C., Bot M., et al. The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis. Circ Res 2010, 106:89-92.
20. Harper A.G., Brownlow S.L., Sage S.O. A role for TRPV1 in agonist-evoked activation of human platelets. J Thromb Haemost 2009, 7:330-338.
21. Huo Y., Ley K.F. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 2004, 14:18-22.
22. Shanmugam N., Roman-Rego A., Ong P., Kaski J.C. Atherosclerotic plaque regression: fact or fiction?. Cardiovasc Drugs Ther 2010, 24:311-317.